BMY

#128
Bristol-Myers Squibb Company Common Stock
57.1 8 USD
+0.62%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
56.82
57.26
년간 변동
42.52
62.89
일일 변동
+0.62%
월간 변동
-0.92%
6달 변화
+15.94%
년간 변동율
+19.50%
이전 종가
56.8 3
Open
56.9 0
저가
56.8 2
High
57.2 6
양
7 641
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 116.77 B
  • Employee 33 K
  • Founded N/A
  • CEO Chris Boerner
  • Website www.bms.com
  • Headquarter Delaware, United States
  • FIGI BBG000DQLV23
  • Industry 종합 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
15.59
주가매출액비율
2.28
주당 배당금
2.49
배당수익률 %
4.62

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000.

뉴스